Oregovomab

Oregovomab
Monoclonal antibody
Type Whole antibody
Source Mouse
Target CA125
Clinical data
Trade names OvaRex
Identifiers
CAS Number 213327-37-8 N
ATC code None
ChemSpider none
KEGG D05269 YesY
Chemical data
Molar mass ca. 150 kg/mol
 NYesY (what is this?)  (verify)

Oregovomab (marketed under the trade name OvaRex) is a mouse monoclonal antibody it binds to the antigen CA125, a carbohydrate antigen. It is designed for the treatment of ovarian cancer.[1]

This drug was developed by AltaRex Corp.

References

  1. Statement On A Nonproprietary Name Adopted By The USAN Council - Oregovomab, American Medical Association.


This article is issued from Wikipedia - version of the Sunday, February 28, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.